Dear reader, the Kingdom's leadership's significant attention to the biotechnology sector underlines its forward-looking vision for achieving sustainable health, economic prosperity, and quality of life.

I propose in this article that “the 13th day of the month of Rajab” be designated annually as the 'Saudi Biotechnology Day.' This is to commemorate the launch of the 'National Biotechnology Strategy' by His Royal Highness Prince Mohammed bin Salman, Crown Prince and Prime Minister. Biotechnology has become a fundamental pillar in the Kingdom's national strategy, reflecting the Crown Prince's insightful vision for a bright future that ensures regional and global leadership and sustainable development.

The 'National Biotechnology Strategy' is a key component in achieving the goals of Saudi Vision 2030. It aims to develop and localize vaccine manufacturing, enhance biomanufacturing, lead in genome research, and improve plant cultivation. This is a significant step towards strengthening the Kingdom's regional and global leadership.

Dear reader, the COVID-19 pandemic has highlighted the importance of biotechnology and the development of effective vaccines for combating infectious diseases. Saudi Arabia has strengthened its vaccine manufacturing capabilities and supported research, development, and innovation towards self-sufficiency and vaccine export. This enhances regional health security and contributes to scientific advancement in this field.

The Kingdom is working to reduce its reliance on imported biopharmaceuticals and ensure its citizens have quick, cost-effective access to essential medicines. This includes localizing the production of key biopharmaceuticals, establishing an integrated biomanufacturing platform, and providing locally accessible, high-quality, affordable medicines.

The 'National Biotechnology Strategy' focuses on genomics to innovate treatments at lower costs, particularly for common genetic diseases in the region. This improves the efficiency of healthcare resources. The strategy includes expanding national genome databases, creating a regulatory environment to support innovation, and using genomic technologies for diagnosis and treatment, aiming to position the Kingdom as a global leader in genomics.

Furthermore, Saudi Arabia aims to improve plant cultivation to secure sustainable food sources, particularly in its arid climate. This will reduce dependence on food imports and enhanceenvironmental sustainability. The strategy involves developing a comprehensive system for crop cultivation, innovative methods, and applying biotechnology to grow trees resistant to dry climates as part of the Saudi Green Initiative.

These initiatives go beyond their four main directions, striving for integration and inclusiveness in various biotechnology applications to meet needs and ensure the growth of the biotechnology sector.

Dear reader, we are confident that under its wise leadership, the Kingdom of Saudi Arabia will emerge as a global hub for biotechnology. The Kingdom possesses all the essential elements to achieve this goal, including specialized ministries and agencies, distinguished scientists, advanced infrastructure, cutting-edge research centers, and sophisticated regulatory and legislative systems. It also boasts active government and private sectors, significant investment power, advanced industrial and manufacturing capabilities, and, most importantly, a clear vision and strategy from an inspiring leadership aiming to position Saudi Arabia as a global force in biotechnology.

The 'National Biotechnology Strategy' benefits for the Kingdom of Saudi Arabia extend beyond achieving self-sufficiency in medicine and food to becoming a global center for innovative biotechnology, aligning with Vision 2030. Through enhancing research and innovation, developing sustainable industries, and improving food and health security, the Kingdom positions itself as a world leader, affirming its role as a significant player in the global economy and scientific community.